|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 349.95 INR | -1.92% |
|
-2.41% | -15.44% |
| 07/03 | Pinnacle Life Science Pvt. Ltd announced that it expects to receive INR 100 million in funding from Aarti Drugs Limited | CI |
| 04/02 | Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026 |
Evolution of the Average Target: Aarti Drugs Limited
Evolution of the Target Price: Aarti Drugs Limited
Changes in Analyst Recommendations: Aarti Drugs Limited
2a27f36a97709db4bbcb69f762db04ab.P-Ci73GmLO9gR-yCNypeMr5mAE4MPxHCS8gOc6w_Ivw.bJqUvyTnW4U5INnzQV0ue9AjeXp2EmSsKOV2H50PVZlcgsyuKdwdpTUrtQ~719727a60955f01698a5e3b1e5c52787
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +34.53% | |||
| +24.53% | |||||
| -1.55% | |||||
| +10.42% | |||||
| +14.23% | |||||
| +14.86% | |||||
| -1.85% | |||||
| +10.24% | |||||
| -4.83% | |||||
| +8.41% | |||||
| Average | +10.90% | |||||
| Weighted average by Cap. | +10.67% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
356.80INR
Average target price
480.00INR
Spread / Average Target
+34.53%
High Price Target
480.00INR
Spread / Highest target
+34.53%
Low Price Target
480.00INR
Spread / Lowest Target
+34.53%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
356.80INR
Average target price
480.00INR
Spread / Average Target
+34.53%
Annual profits - Rate of surprise
- Stock Market
- Equities
- AARTIDRUGS Stock
- Consensus Aarti Drugs Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition